Internal Medicine, Infectious Disease · Tamarac, FL
NPI
1396844478
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
7421 N University Dr, Suite 212
Tamarac, FL, 33321
Phone (954) 721-9494
Groups this clinician bills Medicare through
Medicare paid, 2024
$18K
231 services
Medicare patients, 2024
59
Average age 77
Drug cost, 2024
$1.8M
577 prescriptions
Company payments, 2024
$39.25
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ramon Ramirez was code 99232 (hospital e&m - subsequent), 161 times for 34 patients. In total Ramon Ramirez billed 231 services in 7 codes, and Medicare paid $18K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-08-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 161 | 34 | $67.72 | $11K |
| 99222 Hospital E&M - Initial | Facility | 32 | 29 | $113.10 | $3,619 |
| 99214 Office E&M - Established | Office | 26 | 19 | $91.89 | $2,389 |
By year: 2022 $91K for 1,320 services; 2023 $71K for 1,007 services; 2024 $18K for 231 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ramon Ramirez prescribed most often to Medicare patients was Symtuza (Darunavir/Cob/Emtri/Tenof Alaf), with 171 prescriptions and refills. In total Ramon Ramirez wrote 577 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 171 | 177 | 21 | $840K |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 80 | 80 | 11 | $316K |
| Juluca Dolutegravir/Rilpivirine | 65 | 65 | Under 11 | $223K |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 25 | 25 | Under 11 | $110K |
| Prezcobix Darunavir/Cobicistat | 16 | 16 | Under 11 | $42K |
| Ciprofloxacin Hcl Generic | 14 | 18 | Under 11 | $97.97 |
| Cefuroxime Cefuroxime Axetil | 14 | 14 | Under 11 | $177 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 13 | 13 | Under 11 | $123 |
| Dovato Dolutegravir Sodium/Lamivudine | 12 | 12 | Under 11 | $38K |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 11 | 11 | Under 11 | $41K |
Brand drugs: 413 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Ramon Ramirez $39.25 ($39.25 in general payments such as food, travel and fees) from 1 company. The largest payer was Gilead Sciences, Inc. with $39.25.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 2 | $39.25 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.